Literature DB >> 19235159

Cultivar variations of Australian-grown Danshen (Salvia miltiorrhiza): bioactive markers and root yields.

Chun Guang Li1, Shu Jun Sheng, Edwin C K Pang, Philip Marriott, Brian May, Shufeng Zhou, David Story, Charlie Chang Li Xue.   

Abstract

Danshen (Salvia miltiorrhiza Bunge, Lamiaceae) is a commonly used and highly valued Chinese medicinal herb grown widely in China. In the present work, we studied cultivar variations of Australian-grown Danshen in order to select optimal cultivars for local herbal production. Root yields of seven cultivars, V1-V7, were monitored in a one-year field trial, and bioactive markers, including cryptotanshinone, tanshinone I, tanshinone IIA, and salvianolic acid B, were quantitatively determined using a validated RP-HPLC method. Significant variations were found in root yields, root production efficiencies, and contents of the bioactive marker compounds. Linear correlations were observed among the contents of three tanshinones but not among those of tanshinones and salvianolic acid B. Among the cultivars, V6 was the best cultivar for production of tanshinones, and V4 and V5 were best for production of salvianolic acid B. The findings indicate that it is possible to achieve optimal root yields, and high contents of tanshinones and salvianolic acid B by selecting specific Danshen cultivars.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235159     DOI: 10.1002/cbdv.200700441

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  2 in total

1.  A gDNA microarray for genotyping salvia species.

Authors:  Alexandra Olarte; Nitin Mantri; Gregory Nugent; Hans Wohlmuth; Chun Guang Li; Charlie Xue; Edwin Pang
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

2.  Zhongdanyaozhi No. 1 and Zhongdanyaozhi No. 2 Are Hybrid Cultivars of Salvia miltiorrhiza with High Yield and Active Compounds Content.

Authors:  Meng Chen; Chengmin Yang; Chun Sui; Yue Jin; Jianhe Wei
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.